» Articles » PMID: 18081738

Adipokines and Cytokines in Non-alcoholic Fatty Liver Disease

Overview
Date 2007 Dec 18
PMID 18081738
Citations 155
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Several adipocytokines have been implicated in the pathogenesis non-alcoholic fatty liver disease (NAFLD).

Aim: To assess adipocytokines in NAFLD patients and controls.

Methods: A total of 95 patients (26 non-alcoholic steatohepatitis (NASH), 19 simple steatosis (SS), 38 obese controls and 12 non-obese controls) were included. Fasting serum insulin, glucose, visfatin, resistin, adiponectin, tumour necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8) and IL-6 were determined. Univariate and multivariate analyses were used to compare groups and determine associations.

Results: Serum TNF-alpha and IL-8 were higher in NAFLD patients when compared with both obese and non-obese controls. Analysis involving all patients revealed a significant correlation between serum TNF-alpha and IL-8 (P < 6.319e-08), and between IL-6 and IL-8 (P < 5.271e-15). Homeostatic model assessment scores negatively correlated with adiponectin in NAFLD (P < 0.0032). Serum visfatin was higher in all three obese groups than in non-obese controls (P < 0.02, P < 0.002 and P < 0.008). Visfatin in NASH patients was lower than SS and obese controls. Although TNF-alpha was associated with NAFLD (P < 0.02), it was interdependent on visfatin. In comparison to SS, four factors were independently associated with NASH: age, alanine aminotransferase, IL-8 and adiponectin (P < 0.05). Multivariate analysis indicated that TNF-alpha was the only independent predictor of fibrosis in NASH (P < 0.0004).

Conclusion: These findings support a complex interaction between adipocytokines and the pathogenesis of NAFLD.

Citing Articles

Novel Choline-Deficient and 0.1%-Methionine-Added High-Fat Diet Induces Burned-Out Metabolic-Dysfunction-Associated Steatohepatitis with Inflammation by Rapid Immune Cell Infiltration on Male Mice.

Sakaguchi T, Nagahama Y, Hamada N, Singh S, Mikami H, Maeda K Nutrients. 2024; 16(23).

PMID: 39683544 PMC: 11643772. DOI: 10.3390/nu16234151.


Even moderate liver fat accumulation below conventional fatty liver cutoffs is linked to multiple metabolomic alterations and gestational dysglycemia in Asian women of reproductive age.

Mishra P, Sadananthan S, Yaligar J, Tan K, Chong Y, Gluckman P BMC Med. 2024; 22(1):561.

PMID: 39605006 PMC: 11600899. DOI: 10.1186/s12916-024-03779-0.


Adrenic acid: A promising biomarker and therapeutic target (Review).

Wang Z, Gao H, Ma X, Zhu D, Zhao L, Xiao W Int J Mol Med. 2024; 55(2).

PMID: 39575474 PMC: 11611323. DOI: 10.3892/ijmm.2024.5461.


Dietary insulin index and dietary insulin load in relation to non-alcoholic fatty liver disease: a cross-sectional study.

Motamedi A, Alizadeh S, Osati S, Raeisi T, Homayounfar R Public Health Nutr. 2024; 27(1):e182.

PMID: 39324343 PMC: 11504692. DOI: 10.1017/S1368980024001149.


Prevalence and impact of metabolic associated fatty liver disease in non-metastatic breast cancer women at initial diagnosis: a cross-sectional study in China.

Jiang Z, Liang X, Hu L, Ran L, She R, Ma C Clin Transl Oncol. 2024; .

PMID: 39276288 DOI: 10.1007/s12094-024-03665-4.